Another company I follow (but am not currently invested in) just announced a rebranding. Not entirely sure why, because I haven't followed them closely as of late. But I did think it was interesting to see that the timeline from announcement to the ticker change is about a week. Might be standard, might not.

And I don't know Greek, but I wonder if Livimmune is Greek for "please don't associate us with Nader Pourhassan"?

CELEBRATION, Fla., Feb. 22, 2023 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (“KemPharm,” or the “Company”), announced today that it changed its name to Zevra Therapeutics, Inc. (“Zevra”). This name change reflects the Company’s intensified focus and dedication to developing transformational, patient-focused therapies for rare diseases with limited or no treatment options. In conjunction with the name change, the Company will begin trading under the new ticker symbol “ZVRA” on The Nasdaq Global Market on or about March 1, 2023.

“The adoption of the name Zevra, the Greek word for zebra, is an important step in our journey to become a leading rare disease company since the zebra is the recognized symbol of the rare disease community around the world,” said Richard W. Pascoe, Chief Executive Officer of Zevra.